Severe acute respiratory syndrome coronavirus 2 variants-Possibility of universal vaccine design: A review.
Comput Struct Biotechnol J
; 20: 3533-3544, 2022.
Article
em En
| MEDLINE
| ID: mdl-35765543
ACE2, angiotensin-converting enzyme 2; Antigen; COVID-19; COVID-19, coronavirus disease 2019; Coronavirus; FDA, Food and Drug Administration; FP, fusion peptide; HE, hemagglutinin-esterase; HIV, human immunodeficiency virus; HR1, heptad repeat 1; HR2, heptad repeat 2; Oral drug; RBD, receptor binding domain; Receptor-binding domain; S1-CTD, S1 C-terminal domain; S1-NTD, S1 N-terminal domain; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TMPRSS2, transmembrane protease serine 2; Universal vaccine; mAbs, monoclonal antibodies
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article